Literature DB >> 22496575

Distinct dendritic spine and nuclear phases of calcineurin activation after exposure to amyloid-β revealed by a novel fluorescence resonance energy transfer assay.

Hai-Yan Wu1, Eloise Hudry, Tadafumi Hashimoto, Kengo Uemura, Zhan-Yun Fan, Oksana Berezovska, Cynthia L Grosskreutz, Brian J Bacskai, Bradley T Hyman.   

Abstract

Calcineurin (CaN) activation is critically involved in the regulation of spine morphology in response to oligomeric amyloid-β (Aβ) as well as in synaptic plasticity in normal memory, but no existing techniques can monitor the spatiotemporal pattern of CaN activity. Here, we use a spectral fluorescence resonance energy transfer approach to monitor CaN activation dynamics in real time with subcellular resolution. When oligomeric Aβ derived from Tg2576 murine transgenic neurons or human AD brains were applied to wild-type murine primary cortical neurons, we observe a dynamic progression of CaN activation within minutes, first in dendritic spines, and then in the cytoplasm and, in hours, in the nucleus. CaN activation in spines leads to rapid but reversible morphological changes in spines and in postsynaptic proteins; longer exposure leads to NFAT (nuclear factor of activated T-cells) translocation to the nucleus and frank spine loss. These results provide a framework for understanding the role of calcineurin in synaptic alterations associated with AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496575      PMCID: PMC3354533          DOI: 10.1523/JNEUROSCI.0227-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

Review 1.  Polarised migration: cofilin holds the front.

Authors:  Maryse Bailly; Gareth E Jones
Journal:  Curr Biol       Date:  2003-02-18       Impact factor: 10.834

2.  Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration.

Authors:  Hai-Yan Wu; Kazuhito Tomizawa; Yoshiya Oda; Fan-Yan Wei; Yun-Fei Lu; Masayuki Matsushita; Sheng-Tian Li; Akiyoshi Moriwaki; Hideki Matsui
Journal:  J Biol Chem       Date:  2003-11-19       Impact factor: 5.157

Review 3.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

Review 4.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity.

Authors:  D K Blumenthal; K Takio; R S Hansen; E G Krebs
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

Review 6.  Fluorescence energy transfer as a spectroscopic ruler.

Authors:  L Stryer
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

7.  Nonradioactive assay for protein phosphatase 2B (calcineurin) activity using a partial sequence of the subunit of cAMP-dependent protein kinase as substrate.

Authors:  A Enz; G Shapiro; A Chappuis; A Dattler
Journal:  Anal Biochem       Date:  1994-01       Impact factor: 3.365

8.  Calcineurin: a calcium- and calmodulin-binding protein of the nervous system.

Authors:  C B Klee; T H Crouch; M H Krinks
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

9.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.

Authors:  N A Clipstone; G R Crabtree
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

10.  Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging.

Authors:  Oksana Berezovska; Pavan Ramdya; Jesse Skoch; Michael S Wolfe; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

View more
  36 in total

1.  Interrelationship between Changes in the Amyloid β 42/40 Ratio and Presenilin 1 Conformation.

Authors:  Katarzyna Marta Zoltowska; Masato Maesako; Oksana Berezovska
Journal:  Mol Med       Date:  2016-07-05       Impact factor: 6.354

Review 2.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

3.  A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type.

Authors:  Eleanna Kara; Jordan D Marks; Allyson D Roe; Caitlin Commins; Zhanyun Fan; Maria Calvo-Rodriguez; Susanne Wegmann; Eloise Hudry; Bradley T Hyman
Journal:  J Biol Chem       Date:  2018-06-27       Impact factor: 5.157

Review 4.  Mechanisms and dynamics of AKAP79/150-orchestrated multi-protein signalling complexes in brain and peripheral nerve.

Authors:  Jie Zhang; Mark S Shapiro
Journal:  J Physiol       Date:  2015-03-11       Impact factor: 5.182

5.  NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Gunjan D Manocha; Atreyi Ghatak; Kendra L Puig; Susan D Kraner; Christopher M Norris; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Formation, release, and internalization of stable tau oligomers in cells.

Authors:  Susanne Wegmann; Samantha Nicholls; Shuko Takeda; Zhanyun Fan; Bradley T Hyman
Journal:  J Neurochem       Date:  2016-11-10       Impact factor: 5.372

7.  Pin1 mediates Aβ42-induced dendritic spine loss.

Authors:  Nancy R Stallings; Melissa A O'Neal; Jie Hu; Ege T Kavalali; Ilya Bezprozvanny; James S Malter
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

8.  Activity-dependent transcriptional regulation of M-Type (Kv7) K(+) channels by AKAP79/150-mediated NFAT actions.

Authors:  Jie Zhang; Mark S Shapiro
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

9.  Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.

Authors:  P Hemachandra Reddy; Maria Manczak; Ramesh Kandimalla
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

10.  Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease.

Authors:  Jennifer L Furman; Diana M Sama; John C Gant; Tina L Beckett; M Paul Murphy; Adam D Bachstetter; Linda J Van Eldik; Christopher M Norris
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.